Literature DB >> 7485130

Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.

M Tanemoto1, H Miyakawa, J Hanai, M Yago, M Kitaoka, S Uchida.   

Abstract

Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis has been recently recognized in Graves' disease patients treated with propylthiouracil. We have experienced three adult cases of Graves' disease with main features being renal derangements. All three patients, who were between the ages of 22 and 82 years, had been treated with propylthiouracil for 2 to 5 years after a diagnosis of Graves' disease. After several weeks of upper respiratory tract infection or flu-like symptoms, they abruptly began to manifest proteinuria and hematuria concomitant with severe anemia. Their serum creatinine increased from normal levels to 1.2 to 3.6 mg/dL. Renal biopsy revealed crescentic glomerulonephritis without deposition of immune complexes (ie, pauci-immune type). Crescent formations were observed in 40% to 60% of the glomeruli in all three cases. The serum from the patients revealed positive perinuclear-ANCA and negative cytoplasmic-ANCA (C-ANCA) pattern, and myeloperoxidase (MPO)-ANCA titers were 120 to 502 ELISA Units/mL (normal, < 10 ELISA Units/mL). A withdrawal of propylthiouracil with or without immunosuppressive therapy ameliorated their renal derangements. Graves' disease patients should be placed under vigilant observation by monitoring their urinalysis and serum creatinine, especially when being treated with antithyroid drugs and when suffering from flu-like symptoms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7485130     DOI: 10.1016/0272-6386(95)90441-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Increased levothyroxine requirements presenting as "inappropriate" TSH secretion syndrome in a patient with nephrotic syndrome.

Authors:  M T Collins; A T Remaley; G Csako; F Pucino; M C Skarulis; J E Balow; N J Sarlis
Journal:  J Endocrinol Invest       Date:  2000-06       Impact factor: 4.256

2.  ANCA positive propylthiouracil induced pyoderma gangrenosum.

Authors:  K Gungor; S Gonen; G Kisakol; O Dikbas; A Kaya
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

3.  ANCA associated glomerulonephritis in a patient with mixed connective tissue disease.

Authors:  G Hernández-Molina; E Reyes; J C Crispín
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

4.  A comparison of antineutrophil cytoplasmic antibody prevalence in patients treated and untreated for hyperthyroidism.

Authors:  Turan Calhan; Ebubekir Senateş; Egemen Cebeci; Sayid Shafi Zuhur; Fatma Ozbakır; Uğur Görpe
Journal:  Endocrine       Date:  2010-07-11       Impact factor: 3.633

5.  Analysis of T-cell receptor usage in myeloperoxidase--antineutrophil cytoplasmic antibody-associated renal vasculitis.

Authors:  Kouichi Hirayama; Takashi Ishizu; Homare Shimohata; Yasunori Miyamoto; Tomoko Kakita; Miho Nagai; Yujiro Ogawa; Shogo Fujita; Aki Hirayama; Kunihiro Yamagata; Masaki Kobayashi; Akio Koyama
Journal:  Clin Exp Nephrol       Date:  2009-10-07       Impact factor: 2.801

6.  Titre and affinity of propylthiouracil-induced anti-myeloperoxidase antibodies are closely associated with the development of clinical vasculitis.

Authors:  Hua Ye; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

7.  Benzylthiouracil-induced glomerulonephritis.

Authors:  Sihem Trimeche Ajmi; Rim Braham; Sarra Toumi; Molka Chadli Chaieb; Amel Maaroufi; Koussay Ach; Larbi Chaieb
Journal:  Case Rep Med       Date:  2009-07-06

8.  Churg-Strauss Syndrome following PTU Treatment.

Authors:  R A M Quax; A J G Swaak; M G A Baggen
Journal:  Int J Rheumatol       Date:  2009-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.